SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001682852-24-000023
Filing Date
2024-05-02
Accepted
2024-05-02 06:31:17
Documents
15
Period of Report
2024-05-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mrna-20240502.htm   iXBRL 8-K 31428
2 EX-99.1 exhibit9912024q1pressrelea.htm EX-99.1 165137
  Complete submission text file 0001682852-24-000023.txt   373224

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrna-20240502.xsd EX-101.SCH 2161
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrna-20240502_def.xml EX-101.DEF 14787
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrna-20240502_lab.xml EX-101.LAB 26043
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrna-20240502_pre.xml EX-101.PRE 15429
18 EXTRACTED XBRL INSTANCE DOCUMENT mrna-20240502_htm.xml XML 3821
Mailing Address 325 BINNEY STREET CAMBRIDGE MA 02142
Business Address 325 BINNEY STREET CAMBRIDGE MA 02142 6177146500
Moderna, Inc. (Filer) CIK: 0001682852 (see all company filings)

IRS No.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38753 | Film No.: 24905098
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)